No funding – no company
Danish medtech company Acarix, which will be launching its novel CADScor heart monitoring equipment in the beginning of 2014, has a number of venture capital firms as major investors. But without early funding from a Danish foundation there would not even be a company, says co-founder and former CSO at Coloplast.
by Stefan Singh Kailay
“If we hadn’t received funding from Højteknologifonden (The Danish National Advanced Technology Foundation), there would never have been a company – at least not in relation to this. The funding has been crucial to the establishing of the project.”
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
Med din prøveperiode får du:
Få fuld adgang til dig og dine kollegaer
Start et gratis virksomhedsprøveabonnementRelaterede artikler
Co-founder and CEO wants to replace himself
For abonnenter
Medtech company secures millions from investors
For abonnenter
